Related Experiment Video
Updated: May 12, 2026
A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
Published on: April 26, 2015
Exendin-4 attenuates ischemia-induced ventricular arrhythmias in rats
Insights
Exendin-4 (Ex-4) significantly reduced ischemia-induced ventricular arrhythmias in rats. These protective effects were abolished by inhibiting mitochondrial ATP-sensitive potassium (KATP) channels, suggesting their involvement in Ex-4
Area of Science:
- Cardiovascular Pharmacology
- Electrophysiology
- Mitochondrial Biology
Background:
- Glucagon-like peptide-1 receptor agonist exendin-4 (Ex-4) shows cardiovascular benefits.
- Ischemia-induced ventricular arrhythmias pose a significant clinical threat.
Purpose of the Study:
- To investigate the anti-arrhythmic effects of Ex-4 on ischemia-induced ventricular arrhythmias in rats.
- To explore the role of mitochondrial ATP-sensitive potassium (KATP) channels in mediating these effects.
Main Methods:
- Male rats were treated with Ex-4 (5 μg/kg, i.v.) before inducing myocardial ischemia.
- Mitochondrial KATP channel inhibitor 5-hydroxydecanoic acid (5-HD) was administered to assess its impact on Ex-4's effects.
- Ventricular arrhythmias were monitored during 30 minutes of ischemia.
Main Results:
- Ex-4 significantly reduced the incidence, duration, and severity of ventricular fibrillation (VF) and ventricular tachycardia (VT) + VF.
- Administration of 5-HD completely abolished the protective effects of Ex-4 against arrhythmias.
- These findings indicate a crucial role for mitochondrial KATP channels in Ex-4's cardioprotective mechanism.
Conclusions:
- Exendin-4 demonstrates significant efficacy in attenuating ischemia-induced ventricular arrhythmias in a rat model.
- Mitochondrial KATP channels are implicated as key mediators of Ex-4's anti-arrhythmic properties.
- These findings suggest potential therapeutic applications for Ex-4 in managing cardiac arrhythmias.
Background:
Glucagon-like peptide-1 and its receptor agonist-exendin-4 (Ex-4) have been shown to provide beneficial effects for cardiovascular diseases. This study investigated the effects of Ex-4 on ischemia-induced ventricular arrhythmias in rats.
Methods:
Anesthetized male rats were once treated with Ex-4 (5 μg/kg, i.v.) 1 h before ischemia in the absence and/or presence of 5-hydroxydecanoic acid (5-HD, 10 mg/kg, i.v., a specific inhibitor of mitochondrial ATP-sensitive potassium [KATP] channels) which were once injected 10 min before ischemia. And then subjected to ischemia for 30 min. Ventricular arrhythmias were assessed.
Results:
During the 30-min ischemia, Ex-4 significantly reduced the incidence of ventricular fibrillation (VF) (p < 0.05). The duration of ventricular tachycardia (VT) + VF, the number of VT + VF episodes and the severity of arrhythmias were all significantly reduced by Ex-4 compared to those in myocardial ischemia group (p < 0.05 for all). Administration of 5-HD abolished the protective effects of Ex-4 on VF incidence, the duration of VT + VF, the number of VT + VF episodes and the severity of arrhythmias (p < 0.05 for all).
Conclusions:
This study suggested that Ex-4 could attenuate ischemia-induced ventricular arrhythmias in rats in which mitochondrial KATP channels may be involved.
